Careers

More Than

Acceleron is motivated by patients, driven by science, and fueled by employees. Looking across our industry, you’re likely to find similar statements, so what distinguishes Acceleron?

We believe that our work matters, and that we as individuals matter. If you have ever felt replaceable or interchangeable, then you understand how it feels not to be valued. At Acceleron, we care about your title and your job description, but we also value your experience, your opinions, your ideas, and who you are.

Acceleron is constantly working to nurture and grow our culture of belonging, with an emphasis on diversity, equity, and inclusion. Accelerators should feel that they can bring their full selves to work because they are more than their roles. At Acceleron, we are more than the sum of our parts – we are more than a biotech.


More Than a Leader Slider

More Than a Biotech

Beyond our commitment to patients, we are committed to contributing to the many communities of which we’re a part, be it our industry, the neighborhoods of Cambridge and Greater Boston, or our expanding presence in North America and Europe.

We have always been proud of our positive and engaging culture, but recent events have highlighted the need to strive for even greater diversity, equity, and inclusion (DEI). Having trained our entire organization to recognize unconscious bias, we are now reexamining our hiring practices, pay structures, and promotion guidelines, seeking improvement throughout. As a result, we have introduced new recruitment and retention tools, established a robust DEI Council, and partnered with local organizations with clear DEI-based missions. Our work here isn’t finished, but we are proud of the strides we’ve made toward enhancing a culture of belonging.

Community Impact

Both our long-standing and our growing partnerships with local organizations allow us to affect change beyond our industry.

Employee Wellbeing

We know our people can work anywhere, but they chose Acceleron, so we work to ensure they continue choosing Acceleron every day.

Community Impact

Both our long-standing and our growing partnerships with local organizations allow us to affect change beyond our industry.

Employee Wellbeing

We know our people can work anywhere, but they chose Acceleron, so we work to ensure they continue choosing Acceleron every day.

Strong Science

Above all, our work is dictated by the science. Our deep expertise in the TGF-beta Superfamily has gotten us this far, and we’re just getting started.

Commitment to Patients

95% of rare diseases do not have a cure.* We are motivated by our ability to address this enormous unmet need, which helps us keep our perspective while we work.

Strong Science

Above all, our work is dictated by the science. Our deep expertise in the TGF-beta Superfamily has gotten us this far, and we’re just getting started.

Commitment to Patients

95% of rare diseases do not have a cure.* We are motivated by our ability to address this enormous unmet need, which helps us keep our perspective while we work.

More Than My Role

We all joined Acceleron for similar reasons – a commitment to patients, a passion for science, a desire to be part of something exciting – but who are we beyond our roles? No two of us is alike, and our wonderful mix of skills, perspectives, experiences, and quirks, keeps the everyday from being ordinary.

Frank Salisbury

Vice President, Head of US Marketing for Pulmonary

Past
Past
I have previously worked at several smaller biotechs, including Actelion and InterMune. I was most recently at Sage Therapeutics, here in Cambridge.
Present
Present
My role is Vice President, Head of US Marketing for Pulmonary. So my big project is to lead the US Launch Team for Sotatercept.
Future
Future
I would like to grow with XLRN and find opportunities to contribute across multiple functions.
Milestone
Milestone
My biggest personal accomplishment is that we are raising two healthy and happy kids… They are still young (5 and 3 years old), so they are a lot of fun (and work!).

Claud Jean-Francois

Manager, End User Services

Past
Past
I have been in the Biopharma/Life Sciences industry for the past 15 years (Biogen, Celldex, Momenta, etc.)
Present
Present
My current role is End User Services, Manager. We played a major role supporting the business remotely through Covid-19 shutdown. We implemented a new ticketing system, moved all users to OneDrive, and we’re currently playing a key role in our EU expansion.
Future
Future
As the company grows, I am ready to take on more technical and business responsibilities globally.
Milestone
Milestone
Completed my MBA (Leadership Concentration) degree last year from Bentley University; and I am proud of teaching my 17-year-old daughter how to drive (something I did not get a chance to do with my dad).

CC Windham

Associate Director, TMF

Past
Past
Before I came to Acceleron I was working remote for a large CRO based in Raleigh, NC.
Present
Present
Current role: Associate Director, TMF. Right now I am working on continuing to develop the TMF group and program.
Future
Future
I would love to grow different varieties of clumping bamboo for commercial production.
Milestone
Milestone
Recently, I planted twenty ‘small’ trees by myself. It took me two days and most of my energy was fueled by my favorite Jamaican Blue Mountain coffee and homemade donuts.

More Than Rare

At Acceleron, we say that patients are our north star, and every day, we ask ourselves how we can improve the lives of those living with rare diseases. Although we target specific diseases, we never lose sight of the fact that patients are not diagnoses; that they are defined by so much more.

Moreover, the effects of rare diseases extend far beyond individual patients. A diagnosis can change relationships, lifestyles, and decisions across networks of family, friends, coworkers, caregivers, neighbors, and beyond. While rare diseases can often alter lives indelibly, they needn’t be all-consuming.

We’d like to introduce you to a few members of the rare disease community who might simply be referred to as “patients” and “caregivers.” We think after meeting them, you’ll agree they are more than that. They are, in fact, More Than Rare.

Learn More